Middle East and Africa Clinical Trial Supplies Market – Industry Trends and Forecast to 2029

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 SERVICES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTERS FIVE FORCES

5 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET: REGULATORY SCENARIO

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE

6.1.2 INCREASING INCIDENCE OF CHRONIC DISEASES

6.1.3 GOVERNMENT FUNDS IN R&D INVESTMENTS

6.1.4 ADVANCEMENT OF TECHNOLOGY IN CLINICAL TRIALS SUPPLIES

6.2 RESTRAINTS

6.2.1 ADVERSE EFFECTS OF CLINICAL TRIALS

6.2.2 TRANSPORTATION ISSUE IN CLINICAL TRIAL SUPPLIES

6.2.3 HIGH COST ASSOCIATED WITH THE CLINICAL TRIALS

6.3 OPPORTUNITIES

6.3.1 INCREASING NEW DRUG DEVELOPMENT TRIALS IN EMERGING COUNTRIES

6.3.2 INCREASING DEMAND FOR INNOVATIVE SOLUTIONS IN CLINICAL TRIALS SERVICES

6.3.3 EVOLUTION IN SUPPLY CHAIN MANAGEMENT FOR CLINICAL TRIALS

6.4 CHALLENGES

6.4.1 LOWER PROCEDURE TIME OF CLINICAL TRIALS APPROVAL

6.4.2 LACK OF SKILLED PERSON TO OPERATE DEVICES DURING CLINICAL TRIALS

7 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES

7.1 OVERVIEW

7.2 STORAGE

7.3 MANUFACTURING

7.4 PACKAGING AND LABELLING

7.5 DISTRIBUTION

8 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASES

8.1 OVERVIEW

8.2 PHASE III

8.3 PHASE II

8.4 PHASE IV

8.5 PHASE I

9 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE

9.1 OVERVIEW

9.2 ONCOLOGY

9.3 CARDIOVASCULAR DISEASES

9.4 DERMATOLOGY

9.5 METABOLIC DISORDERS

9.6 INFECTIOUS DISEASES

9.7 RESPIRATORY DISEASES

9.8 CNS AND MENTAL DISORDERS

9.9 BLOOD DISORDERS

9.1 OTHERS

10 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER

10.1 OVERVIEW

10.2 CONTRACT RESEARCH ORGANIZATIONS

10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

11 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY REGION

11.1 MIDDLE EAST & AFRICA

11.1.1 SOUTH AFRICA

11.1.2 REST OF MIDDLE EAST & AFRICA

12 MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.1.5.1 PARTNERSHIP

14.2 ALMAC GROUP

14.2.1 COMPANY SNAPSHOT

14.2.2 COMPANY SHARE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENTS

14.3 CATALENT INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 SERVICE PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.3.5.1 SERVICE EXPANSION

14.4 CLINIGEN GROUP PLC

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.4.5.1 PARTNERSHIP

14.5 MOVIANTO

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 SERVICE PORTFOLIO

14.5.4 RECENT DEVELOPMENT

14.5.4.1 ACQUISITION

14.6 PCI PHARMA SERVICES

14.6.1 COMPANY SNAPSHOT

14.6.2 SERVICE PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 SHARP

14.7.1 COMPANY SNAPSHOT

14.7.2 SERVICE PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.8 ALIUM MEDICAL LIMITED

14.8.1 COMPANY SNAPSHOT

14.8.2 SERVICE PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 ANCILLARE, LP

14.9.1 COMPANY SNAPSHOT

14.9.2 SERVICE PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.1 BIOCAIR

14.10.1 COMPANY SNAPSHOT

14.10.2 SERVICE PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 BIONICAL LTD.

14.11.1 COMPANY SNAPSHOT

14.11.2 SERVICE PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.11.3.1 SERVICE LAUNCH

14.12 CLINICAL SUPPLIES MANAGEMENT HOLDINGS,INC

14.12.1 COMPANY SNAPSHOT

14.12.2 SERVICE PORTFOLIO

14.12.3 RECENT DEVELOPMENT

14.13 KLIFO

14.13.1 COMPANY SNAPSHOT

14.13.2 SERVICE PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.13.3.1 ACQUISTION

14.14 MYONEX

14.14.1 COMPANY SNAPSHOT

14.14.2 SERVICE PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 PAREXEL INTERNATIONAL CORPORATION

14.15.1 COMPANY SNAPSHOT

14.15.2 SERVICE PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.15.3.1 COLLABORATION

14.16 SIRO CLINPHARM PRIVATE LIMITED

14.16.1 COMPANY SNAPSHOT

14.16.2 SERVICE PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS